Municipal Employees Retirement System of Michigan acquired a new position in Natus Medical Inc (NASDAQ:BABY) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 9,670 shares of the medical equipment provider’s stock, valued at approximately $329,000.
Several other institutional investors have also recently modified their holdings of BABY. Pearl River Capital LLC purchased a new stake in Natus Medical during the 4th quarter worth approximately $30,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Natus Medical by 51.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,495 shares of the medical equipment provider’s stock valued at $85,000 after acquiring an additional 845 shares during the last quarter. Paloma Partners Management Co purchased a new stake in shares of Natus Medical in the 3rd quarter valued at $218,000. Janney Montgomery Scott LLC boosted its holdings in shares of Natus Medical by 5.5% in the 4th quarter. Janney Montgomery Scott LLC now owns 7,097 shares of the medical equipment provider’s stock valued at $242,000 after acquiring an additional 370 shares during the last quarter. Finally, Piedmont Investment Advisors Inc. boosted its holdings in shares of Natus Medical by 4.3% in the 4th quarter. Piedmont Investment Advisors Inc. now owns 8,019 shares of the medical equipment provider’s stock valued at $273,000 after acquiring an additional 333 shares during the last quarter. 97.22% of the stock is currently owned by hedge funds and other institutional investors.
Shares of BABY traded up $0.47 during trading hours on Friday, hitting $27.54. The stock had a trading volume of 195,472 shares, compared to its average volume of 372,600. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.80 and a quick ratio of 1.24. Natus Medical Inc has a fifty-two week low of $23.58 and a fifty-two week high of $37.95. The stock has a market cap of $935.15 million, a P/E ratio of 19.39 and a beta of 0.54.
Several analysts have recently commented on BABY shares. ValuEngine downgraded shares of Natus Medical from a “buy” rating to a “hold” rating in a report on Tuesday, January 29th. Zacks Investment Research downgraded shares of Natus Medical from a “hold” rating to a “strong sell” rating in a report on Friday, February 15th. BidaskClub downgraded shares of Natus Medical from a “hold” rating to a “sell” rating in a report on Friday, February 8th. TheStreet downgraded shares of Natus Medical from a “c-” rating to a “d+” rating in a report on Thursday, April 25th. Finally, William Blair reaffirmed a “market perform” rating on shares of Natus Medical in a report on Saturday, January 12th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $36.00.
In other Natus Medical news, VP Austin Francis Noll III sold 14,250 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $26.43, for a total transaction of $376,627.50. Following the completion of the transaction, the vice president now directly owns 99,443 shares in the company, valued at $2,628,278.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert A. Gunst sold 8,304 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $28.09, for a total transaction of $233,259.36. Following the transaction, the director now owns 32,392 shares of the company’s stock, valued at $909,891.28. The disclosure for this sale can be found here. Over the last quarter, insiders sold 38,858 shares of company stock valued at $1,052,487. Company insiders own 5.50% of the company’s stock.
About Natus Medical
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.
Recommended Story: Convertible Shares
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.